mercredi 22 mars 2017

Onco Actu du 22 mars 2017

2.7 Etiologie - Obésité

Womb cancer risk grows with extra waist weight, study suggests [The Guardian]

3.1 Tabac

Tobacco treaty has helped cut smoking rates, but more work needed [Reuters]

4.9 Dép., diag. & prono. - Sein

Genomic screening may help predict breast cancer survival [Stanford Medicine]

5. Traitements

Patients’ reports may aid prostate cancer treatment choice [STAT]

Training viruses to be cancer killers [Cancer Research UK]

Stem-Cell Based Tool May Help Measure Heart Toxicity of Cancer Drugs [NCI]

5.12.1 Immunothérapies - partenariats

Pierre Fabre pens oncology pact with atomic energy spinout [Fierce Biotech]

Stimunity Signs an Exclusive License Agreement with Institut Curie and Inserm [Stimunity]

Pierre Fabre and H-Immune Announce Research Partnership to Develop Cancer Immunotherapies [Pierre Fabre]

5.12.2 Immunothérapies - CAR-T

This is Not a Test: RMAT Designation Goes Live [FDA Voice]

5.12.4 Immunothérapies - Essais

Pembrolizumab Shows Promise in Treatment of Mesothelioma [Penn Medicine]

5.12.5 Immunothérapies - Pharma

Struggling Heat gets a warm response to a snapshot on cancer vax data [EndPoints]

5.2.3 Pharma - économie

Investors left feeling blue as Cerulean admits defeat on cancer pipeline [Fierce Biotech]

6.1 Observation

Contraceptive pill protects women against cancer for 35 years, major study suggests [The Telegraph]

6.2 Implants mammaires

Breast Implants: Update - Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) [FDA]

9 Deaths Are Linked to Rare Cancer From Breast Implants [NY Times]

6.6 Publications

Google Scholar is a serious alternative to Web of Science [LSE Impact Blog]

6.9 Controverses

The bias hunters: Study explores where science goes wrong [Stanford Medicine]